Dietary Supplement Implied Disease Claims Still Not Suitable - FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA affirms its position that "structure/function claims should not imply disease treatment or prevention" in the agency's final rule on dietary supplement claims criteria published in the Jan. 6 Federal Register.
You may also be interested in...
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.
Fewer Structure/Function Claims Deemed Inappropriate By FDA In 1999
Cold, allergy and immune system claims were the most commonly cited statements in FDA "courtesy" letters issued to dietary supplement companies in 1999, although the number of letters addressing these conditions declined from 1998.